Added to YB: 2026-08-13
Pitch date: 2026-08-10
RMD [bullish]
ResMed Inc.
+1.73%
current return
Author Info
No bio for this author
Company Info
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally.
Market Cap
$31.8B
Pitch Price
$218.12
Price Target
N/A
Dividend
1.19%
EV/EBITDA
14.49
P/E
21.28
EV/Sales
5.50
Sector
Health Care Equipment and Supplies
Category
value
ResMed global leader in sleep apnea devices.
RMD: Sleep apnea leader (near-duopoly w/ Philips), 22% ROIC, 60%+ GM, net cash, 100%+ FCF conversion. FY26 rev +10% $5.65B, EPS +17% $11.17. At ~$219, fwd P/E 17.5x, EV/EBITDA 14x — cheapest in a decade on GLP-1 fears. Data shows GLP-1 boosts CPAP starts/resupply; ~80% OSA undiagnosed. $1.85B returns FY27. Risk: long-tail substitution. Asymmetry favors long.
Read full article (2 min)